The three licensed places to inject Mounjaro (tirzepatide) are the abdomen (tummy), the front of the thigh, and the back of the upper arm. No single site works better than another for weight loss — Mounjaro is absorbed reliably from all three — so the best place is the one you can reach comfortably and rotate each week.
Mounjaro is a once-weekly injection given just under the skin (subcutaneously), not into muscle or a vein. Choosing an area with a little fatty tissue and changing the exact spot each time keeps the injection comfortable and your skin healthy. Mounjaro is a prescription-only medicine, available only after a clinical consultation with a GPhC-registered prescriber.
Where exactly should you inject Mounjaro?
You can inject Mounjaro into any of three subcutaneous sites: the abdomen, keeping at least 5cm (about two finger-widths) away from your belly button; the front of your thigh; or the back of your upper arm. These are the areas licensed for tirzepatide because they have a layer of fat under the skin that absorbs the medicine steadily.
Each area has practical pros and cons:
| Site | Why people choose it | Things to note |
|---|---|---|
| Abdomen (tummy) | Easy to see and reach; plenty of fatty tissue; most popular choice | Stay at least 5cm from the belly button; avoid any area that is bruised or scarred |
| Front of thigh | Simple to do yourself while sitting; good if the tummy is sore | Use the fleshy front/outer part, not the inner thigh |
| Back of upper arm | Useful for rotating sites; less sensation for some people | Hard to reach yourself — often easier with help from someone else |
Is one injection site better than another for weight loss?
No — there is no evidence that injecting Mounjaro into the abdomen, thigh or upper arm changes how much weight you lose. Mounjaro is absorbed effectively from all three subcutaneous sites, so weight-loss results depend on the dose, consistent weekly use and lifestyle support, not on which licensed site you pick.
In the SURMOUNT-1 trial, participants on the 15mg dose lost on average 22.5% of body weight over 72 weeks, alongside lifestyle support (Jastreboff AM, et al. N Engl J Med. 2022). Individual results vary; not everyone reaches this. The injection site is about comfort and skin care — choose whichever you find easiest to use correctly every week.
Why should you rotate your Mounjaro injection sites?
Rotating where you inject Mounjaro prevents a lumpy, hardened area under the skin called lipohypertrophy, which can form if you keep injecting the exact same spot. Lumpy tissue can make absorption less predictable, so moving the site protects both your skin and the medicine's effect.
A simple approach is to pick one area (for example your tummy) and inject at least 2–3cm away from your last spot each week, working around the area before switching to another site. You can inject into the same general region repeatedly as long as you keep moving the precise point.
How do you inject Mounjaro step by step?
- Wash your hands and take the pre-filled pen from the fridge — letting it reach room temperature for about 30 minutes can make the injection more comfortable.
- Check the medicine is clear and colourless and that it is in date.
- Choose your site (abdomen, thigh or back of upper arm) and clean the skin; let it dry.
- Place the flat end of the pen firmly against the skin and press the button as instructed in your pen's leaflet.
- Hold the pen in place until the injection is complete (usually until the second click or when the indicator stops), then lift it away.
- Dispose of the pen in a sharps bin — never in household waste.
Always follow the patient information leaflet supplied with your specific pen, and ask your prescriber or pharmacist if you are unsure. You will receive guidance as part of your online consultation and ongoing support.
Which places should you avoid injecting Mounjaro?
Avoid injecting Mounjaro into skin that is bruised, tender, red, hard, scarred or affected by a rash, and stay at least 5cm away from your belly button. You should also avoid injecting into muscle or a vein — Mounjaro is designed to sit in the fatty layer just under the skin, which is why the abdomen, thigh and upper arm are used.
Do not inject through clothing, and do not reuse a pen. If an area becomes consistently sore or lumpy, switch to a different site and mention it at your next prescriber review.
What side effects should you watch for?
The most common side effects of Mounjaro (affecting more than 1 in 10 people) are nausea, diarrhoea, constipation, vomiting, decreased appetite and fatigue. These are usually mild and often ease as your body adjusts, which is why Mounjaro is started at 2.5mg and increased gradually.
Rare but serious effects include severe allergic reaction, acute pancreatitis, severe hypoglycaemia (low blood sugar), severe gastrointestinal disease and worsening diabetic retinopathy — seek medical help if you experience severe or persistent symptoms. You can report suspected side effects to the MHRA via the Yellow Card scheme at https://yellowcard.mhra.gov.uk/.
How does Mounjaro compare with other weight-loss options?
Mounjaro (tirzepatide) is a weekly injection that activates two gut-hormone receptors, GLP-1 and GIP. If injecting is not for you, other prescription options exist, including the Wegovy injection (weekly semaglutide), the once-daily Wegovy Tablet taken on an empty stomach, and Foundayo (orforglipron), a once-daily tablet taken at any time with or without food or water.
All of these are prescription-only and share a similar side-effect profile. A prescriber decides what is clinically appropriate for you — you can compare them on our treatments overview or weight-loss injections page.
Who can be prescribed Mounjaro?
Mounjaro may be prescribed to adults aged 18 and over with a BMI of 30 or more, or a BMI of 27 to 30 with a weight-related condition such as type 2 diabetes, high blood pressure or sleep apnoea. It is prescribed only if clinically appropriate after a free online consultation with a GPhC-registered prescriber.
Mounjaro is not suitable if you are pregnant, planning pregnancy or breastfeeding, have type 1 diabetes, a personal or family history of medullary thyroid cancer or MEN2, a history of pancreatitis, severe gastrointestinal disease, an active eating disorder, severe liver or kidney impairment, or a known allergy to tirzepatide.
This article is for information only and is not a substitute for personalised medical advice. Weight-loss medicines are prescription-only, are not suitable for everyone, and are prescribed only after a clinical consultation with a GPhC-registered prescriber. Individual results vary. Always speak to a UK-registered pharmacist or doctor before starting or changing any prescription medication.
